Jennifer Michaels
CEO & Co-FounderNorCal Seeds & GeneticsJennifer Michaels is the CEO and Co-Founder of NorCal Seeds & Genetics, a legacy cannabis genetics company based in Northern California. For more than two decades, Jennifer has worked alongside her husband and business partner, Jay Michaels, to steward one of the world's most extensive private cannabis germplasm repositories, preserving thousands of cultivars through long-term breeding, preservation and genetic stewardship.
Jennifer's work focuses on the intersection of genetic stewardship, scientific validation, and commercial strategy. She leads initiatives that help transform cannabis genetics into strategic business assets through documentation, advanced genomic and chemical analysis, intellectual property strategy, and scientific collaboration. Her work bridges legacy breeding with modern science, helping cultivators, researchers and industry partners better understand, validate and maximize the long-term value of cannabis genetics.
Jennifer brings a unique perspective that spans legacy cultivation, genetic preservation, business strategy and the evolving scientific and regulatory landscape of cannabis. She believes the future of cannabis will be shaped not only by what is cultivated, but by what is verified, preserved, authenticated, and strategically valued.
Genetics as Strategy: Continuous Optimization for Commercial Cannabis Cultivation
The cannabis market moves faster than your cultivation cycles. By the time a trend hits the shelf, most teams are still six months behind, scrambling
The cannabis market moves faster than your cultivation cycles. By the time a trend hits the shelf, most teams are still six months behind, scrambling to source, trial, and scale genetics that buyers already expect. That lag costs margin, shelf space
The cannabis market moves faster than your cultivation cycles. By the time a trend hits the shelf, most teams are still six months behind, scrambling to source, trial, and scale genetics that buyers already expect. That lag costs margin, shelf space, and competitive position.
This session shows commercial growers how to flip that script. You'll learn how leading operators replace reactive trend-chasing with a structured genetic program built
The cannabis market moves faster than your cultivation cycles. By the time a trend hits the shelf, most teams are still six months behind, scrambling to source, trial, and scale genetics that buyers already expect. That lag costs margin, shelf space, and competitive position.
This session shows commercial growers how to flip that script. You'll learn how leading operators replace reactive trend-chasing with a structured genetic program built on continuous sourcing, trialing, and evaluation. We'll connect each decision to commercial viability, so genetics become a strategic asset rather than a guessing game.
